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The activity of the White Line Inducing Principle (WLIP) and tolaasin I, produced by virulent strains of Pseudomonas reactans and
Pseudomonas tolaasii, respectively, was comparatively evaluated on lipid membranes. Both lipodepsipeptides were able to induce the release
of calcein from large unilamellar vesicles. Their activity was dependent on the toxin concentration and liposome composition and in particular it
increased with the sphingomyelin content of the membrane. Studies of dynamic light scattering suggested a detergent-like activity for WLIP at
high concentration (>27 μM). This effect was not detected for tolaasin I at the concentrations tested (<28 μM). Differences were also observed in
lipodepsipeptides secondary structure. In particular, the conformation of the smaller WLIP changed slightly when it passed from the buffer
solution to the lipid environment. On the contrary, we observed a valuable increment in the helical content of tolaasin I which was inserted in the
membrane core and oriented parallel to the lipid acyl chains.
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Recent studies have demonstrated that brown blotch disease
of Agaricus bisporus and yellowing of Pleurotus ostreatus are
complex diseases [1–3]. Besides Pseudomonas tolaasii, known
by long time as the causal agent of the brown blotch disease on
A. bisporus [4], also other Pseudomonas spp., including P.
reactans, cause the disease symptoms even though in a
different way [5–7]. Furthermore, P. reactans has been recently
demonstrated as the causal agent of the yellowing of Pleurotus
eryngii [8].
P. reactans is a bacterial entity not yet classified, known as a
saprophytic bacterium associated to the cultivated mushrooms
and useful in the white line assay for the identification of P.
tolaasii [9]: strains of P. reactans produce in culture an☆ This paper is dedicated to the memory of Gianfranco Menestrina.
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doi:10.1016/j.bbamem.2006.06.023extracellular substance, called the White Line Inducing Prin-
ciple (WLIP), known for its ability to interact with tolaasin I,
the main virulence factor of P. tolaasii, and to form a white
precipitate in the agar [9]. The potential involvement of both
the bacteria in the development of some diseases on fungi and
the specific interaction occurring between their main secondary
metabolites, prompted us to study these molecules in a
comparative way. WLIP is a lipodepsipeptide (LDP) with a
molecular weight of 1125 Da composed of a N-terminal β-
hydroxydecanoic acid and a peptide moiety of nine aminoa-
cids, six of which are in the D form (Fig. 1). The molecule
contains a lactone ring between D-allo-threonine (D-Thr3) and
the C-terminal L-isoleucine (Ile9) [10]. WLIP is structurally
similar to another lipodepsipeptide called viscosin [11,12],
except for the chirality of leucine in position 5 which has D
configuration in WLIP and L configuration in viscosin. Also
tolaasin I from P. tolaasii is a lipodepsipeptide with a molecular
weight of 1985 Da composed of 18 aminoacids, eleven of
which are in the D form. The primary structure (Fig. 1),
elucidated by Nutkins et al. [13], bears a β-hydroxyoctanoic
Fig. 1. Primary structure of WLIP and Tolaasin I. Non standard amino acids indicated are as follows: aThr, allo threonine; ΔBut, 2,3-dehydro-2-aminobutyric acid;
Hse, homoserine; Dab, 2,4-diaminobutyric acid.
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successive D-amino acids in the N-terminal region of the
peptide (Pro2–Val8), with a Ser–Leu–Val repeat, and then
alternate L- and D-amino acids. It also contains a 2,3-
dehydro-2-aminobutyric acid (ΔBut) residue at positions 1
and 13, a D-homoserine (D-Hse16), and a D-2,4-diaminobu-
tyric acid (D-Dab17). Finally, a lactone ring is formed
between the hydroxyl of D-Thr14 and the C-terminal L-Lys18.
In addition to tolaasin I and II [13] other five analogues,
namely tolaasin A–E, have been shown to be produced by
strains of P. tolaasii. The primary structure and the
antimicrobial activity of these new analogues have also
been reported [14].
Tolaasin I is considered to be the main virulence factor of the
bacterium and appeared to cause the mushroom tissue alteration
by disrupting the cell membrane through the formation of
transmembrane pores [15–19]. In comparison to other lipo-
depsipeptides produced by phytopathogenic or mycopathogenicbacteria [20] the biological properties of WLIP and its possible
role in the disease process are less defined.
The novelty of the pathogenetic capability of P. reactans and
particularly the fact that avirulent variants of the pathogen have
also lost the ability to produce WLIP [3] suggest that this
metabolite may be important in the P. reactans–mushrooms
interactions. However, even though the haemolytic and the
antimicrobial activity of WLIP and its interactions with
synthetic membranes have been recently demonstrated [2,3,8],
the mechanism involved is not yet defined.
Here, the effects of WLIP directly on model membranes of
different lipid composition, also in comparison to tolaasin I, are
reported. Furthermore, data on the LDPs mode of action and the
molecularity of the permeabilising unit are analysed. In
addition, the changes in the secondary structure occurring
when the above molecules passed from the aqueous buffer to
the membrane are reported. In particular, it was possible to
analyse the conformation of WLIP and tolaasin I during their
1715M. Coraiola et al. / Biochimica et Biophysica Acta 1758 (2006) 1713–1722interaction with the lipid membrane, i.e. their natural target, and,
in the case of tolaasin I, to calculate the molecule orientation
with respect to the lipid acyl chains.
2. Materials and methods
2.1. Chemicals
Lipid used were egg phosphatidylcholine (PC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) and sphingomyelin (SM) from Avanti Polar
Lipids (Alabaster, AL, USA), ergosterol (Erg) from Sigma, cholesterol (Chol)
from Fluka. Calcein, EDTA, and Sephadex G-50 were from Sigma, Triton X-100
from Merck. In FTIR experiments solvents used were trifluoroethanol (TFE)
from Sigma, dimethyl sulfoxide (DMSO) and hexafluoroisopropanol (HFIP)
from Riedel-de Haën, and sodium dodecylsulfate (SDS) from Pharmacia. The
isolation and purification of LDPs were performed as described earlier [3,14,21]
with minor modification.
2.2. Calcein release assay
Large unilamellar vesicles (LUVs) loaded with calcein at a self-quenching
concentration (80 mM) have been used to measure membrane permeabilisation
as reported byKayalar andDuzgunes [22]. LUVswere prepared using pure lipids
(4÷8mg/ml) by extrusion through two stacked polycarbonate filters with 100 nm
pores [23]. The external non encapsulated calcein was removed by washing the
vesicle suspension through Sephadex G-50 minicolumns, equilibrated with the
experimental buffer [24]. The assay was performed with the microplate
fluorimeter (Fluostar, BMG, Offenburg, Germany) as described in Dalla Serra
et al. [25]. Unspecific binding of protein and liposomes to plastic microplate
walls were strongly reduced by pre-treating the microplate with 0.1 mg/ml of
Prionex (Pentapharm, CH). Aliquots of washed LUVs were dispensed into each
well to a final lipid concentration of 6–12 μM in 200 μl of 20 mM Tris–HCl,
100 mM NaCl, 1 mM EDTA, pH 7.0 (hereafter buffer A) containing the desired
amount of toxin. Interferometric filter at 485 nm in excitation and at 538 nm in
emission were used. Maximum calcein release (Fmax) was determined by adding
1 mM Triton X-100 and used as 100%. The extent of permeabilisation, R%, was
then calculated as follows:
R% ¼ 100 Ffin  Finð Þ= Fmax  Finð Þ
whereFin andFfin represent the initial and final (after 45min) value of fluorescence
before and after toxin addition, respectively.Before eachassayWLIPwasdissolved
in DMSO in order to favour its solubility; the same amount of DMSO tested alone
did not induce any permeabilisation of LUVs (data not shown).
Data of calcein release were further analysed using a statistical model first
introduced by Parente et al. [26] and improved by Rapaport et al. [27]. This
empirical model allowed the estimation of the three main parameters governing
the permeabilisation process, i.e. the partition coefficient (K1) of toxin
monomers from the aqueous solution into the lipid membrane, the aggregation
process of membrane-bound monomers (K2), and the number of monomers (M)
necessary for the formation of an active pore. The reported values were
calculated as follows: a set of curves was generated by freely varying each of the
three parameters in a wide range, curves with a χ2 (chi square distribution) value
comprised between the minimal (χmin
2 ) and χmin
2 + (χmin
2 /2) were selected and
their parameters were used to calculate the average±SD.
2.3. Dynamic light scattering
The dimension of vesicles was measured by dynamic light scattering
(DLS) at a fixed angle (90°) following procedures previously reported in
Alvarez et al. [24]. The light scattering apparatus (Zetasizer3, Malvern, UK)
was upgraded with a 30 mW laser diode light source (675 nm), 64 channels
autocorrelator and a quartz cell with a Peltier temperature control. The quartz
cell has been filled with 0.5 ml buffer A and 40 μl of PC LUVs. The final
lipid concentration was 80 μM.
The calculated autocorrelation functions were submitted to computer
analysis (with the Malvern Application Software) using the method ofcumulants. From the first cumulant the mean intensity-weighted diffusion
coefficient (D) was obtained. The D value is used to provide information on the
size applying the Stokes–Einstein relation to obtain the mean diameter, d
d ¼ kT=ð3pηDÞ
where kT is the thermal energy (4.12×10−21 J at 25 °C) and η is the viscosity of
the solvent (0.89×10−3 kg/m.s for water at 25 °C).
2.4. Fourier-transform infrared spectroscopy experiments
Attenuated total reflection (ATR) Fourier transform infrared spectroscopy
(FTIR) was used to investigate the changes in the LDPs secondary structure when
they passed from the buffer solution to an organic solvents (TFE, HFIP) to an SDS
solution or to the lipid phase. This was done analysing the amide I′ band as
previously described [28]. Briefly, samples were suspended in the buffer or in an
appropriate solvent (WLIP was always reconstituted in 20% DMSO to favour its
solubility), deposited on a 10-reflections germanium crystal (45° cut) and gently
dried by nitrogen flushing. For the analysis of LDPs in the lipid phase, both
substances in 10 mMHEPES pH 7.4 (hereafter buffer B) were incubated for 1 h at
room temperature with palmitoyl-oleoyl-phosphatidylcholine (POPC) LUVs
prepared in buffer B as described above, at a toxin to lipid molar ratio (T/L) of
1/20 and 1/50 for WLIP and tolaasin I, respectively. In the case of WLIP the
incubation was performed twice in order to favour toxin binding. After incubation
the mixtures were centrifuged in an Optima TL ultracentrifuge (Beckman, USA),
using a fixed-angle rotor (TLA-100.2) at 350,000×g, for 3 h at 4 °C. The resultant
pellet was resuspended in buffer B (100 μl) and directly deposited on the
germanium crystal. Spectra of hydrated and deuterated film were collected, in an
ATR geometry, using a FTS 185 spectrometer (Bio-Rad, USA), with an MCT-
detector. By interposing a rotatingKRS5 wire-grid polarizer we obtained polarized
spectra to calculate the orientation of a structural element [29]. The dichroic ratio
of the tolaasin I band at 1738 cm−1 (which corresponds to the stretching of the
phospholipid carbonyl groups), provided a good estimation for Riso (i.e. the
dichroic ratio for an isotropic distribution of dipoles) [30], and therefore was used
to calculate the dichroic spectrum in the amide I′, as described in Results.
To estimate the secondary structure content, the amide I′ band in the region
1700–1600 cm−1 was analysed using a set of Gaussian components whose
frequencies were assigned to different structural elements in the standard way as
follows: band at 1680±3 cm−1 and 1621±5 cm−1 β-structures; bands in the
region 1660±3 cm−1, helical-structure; band at 1641±3 cm−1, random coil; band
at 1610±5 cm−1, side chains contribution. In the case of tolaasin I, a single band
at 1672 cm−1 appeared indicating the presence of trifluoroacetic acid (TFA) from
the purification process. Suchminor bandwas digitally removed and the resulting
spectra were comparedwith those collected from samples without TFA (removed
by lyophilizing the sample several times in the presence of 10 mMHCl [30]). No
significant differences were found and the results after analysis were averaged.3. Results
3.1. Calcein release assay
WLIP and tolaasin I were both able to permeabilise LUVs of
different lipid composition, although in most of the cases
tolaasin I displayed higher porating activity (Table 1). In
particular, on PC LUVs tolaasin I provoked calcein efflux at
five times lower concentrations than WLIP.
The activities of both toxins showed similar responses to
changes in the membrane lipid composition, even if WLIP
activity was only slightly influenced by lipid changes. Thus,
tolaasin I activity was enhanced by the SM content in the
membrane but it decreased with increasing the sterols content
(Table 1 and Fig. 2). A similar tendency has already been
described for other LDPs [25,31]. However, differences were
observed if Chol and Erg were compared: in fact, tolaasin I was
Table 1
Permeabilising activity of WLIP and tolaasin I on vesicles of different lipid composition and a statistical analysis of their pore-formation mechanism
Lipid composition a
(mol %)
WLIP Tolaasin I
PC SM Sterol 1/C50
b (μM−1) K1
c, d (M−1) M d, e K2
d, f 1/C50
b (μM−1) K1
c, d (M−1) M d, e K2
d, f
100 0 0 0.59±0.04 50±20 8±1 533±451 2.8±0.4 233±52 6±1 5.2±2.6
50 50 0 1.41±0.05 100±30 6±1 200±340 4.9±0.2 673±179 6±1 1.7±1.1
50 33 16.5* 0.70±0.05 100±30 12±1 217±247 2.8±0.2 200±50 6±1 12±12
50 16.5 33* 0.59±0.01 50±20 8±1 533±451 1.2±0.2 100±30 7±1 19.7±17.4
50 0 50* 0.45±0.01 50±20 11±1 533±451 0.4±0.1 50±20 7±1 0.8±0.3
50 33 16.5§ 0.70±0.03 100±30 12±1 413±440 2.5±0.2 250±54 7±1 2.8±1.7
50 16.5 33§ 0.59±0.08 50±20 8±1 533±451 1.3±0.1 100±30 7±1 30±20
50 0 50§ 0.54±0.01 50±20 10±1 533±451 1.0±0.2 50±20 5±1 30±20
a Lipid mixtures are reported on a molar base. PC: egg phosphatidylcholine; SM: sphyngomyelin; the sterol included in the vesicles was cholesterol* and ergosterol§.
b The permeabilising activity is expressed as the reciprocal of the concentration of toxin causing 50% of calcein release (C50). Data are average±S.D. of al least two
different experiments.
c The partition coefficient of toxin monomers into the liposome.
d Data are average±S.D. of at least three different experiments.
e The number of monomers necessary for the formation of an active pore.
f The aggregation process of membrane-inserted monomers.
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more pronounced when sterols and PC were present in equal
molar amount, and decreased with the sterol content in the
membrane.
Interestingly, the analysis of these data with the Parente–
Rapaport model (parameters are reported in Table 1) showed a
direct correlation between the permeabilising activity and theFig. 2. Dose dependence activity of tolaasin I on liposomes with different lipid
composition: Calcein loaded liposomes were exposed to different peptide
concentrations. The percentage of calcein release was determined after 45 min as
a function of the toxin/lipid ratio (T/L) and expressed as % of the maximal value
obtained with TritonX-100. Experiments were done at constant lipid
concentration (about 9 μM). The true toxin concentration used was reported
in the upper scale of the panel. Lines through the points are best fit according to
the statistical model described in the text. Best values of fitting parameters are
reported in Table 1. Vesicles were prepared with the following compositions
expressed in molar ratio: (down triangle) PC:SM (50:50), (up triangle) PC:SM:
Chol (50:33:16.5), (circle) PC:SM:Chol (50:16.5:33), (square) PC:Chol (50:50).empirical parameter K1 which is related to the partition
coefficient of tolaasin I between water and lipid phase. The
number of monomers constituting the active conducting unit
(M) was instead always in the range of 6±1.
In comparison to tolaasin I, WLIP showed a higher slope of
its dose-dependence curve, similar to a detergent-like behaviour
[25].Fig. 3. Effect of toxins on vesicle size as determined by dynamic light scattering:
The treatment of phosphatidylcholine vesicle with tolaasin I (open square) and
WLIP (close circle) caused changes in vesicle average size (Δ diameter) which
was reported vs. the toxin concentration (T), normalized to the vesicle diameter
in the absence of toxin. Experiments were obtained at constant lipid
concentration (80 μM). The toxin/lipid ratio (T/L) was reported in the upper
scale of the same panel. Inset: in this case we analysed the variation of the
scattered light intensity (Δ ILS), normalized to the intensity value in the absence
of toxin. Other parameters are as above.
Fig. 5. FTIR-ATR spectra of WLIP in buffer and in lipid mimetic environments:
(A) Analysis of the amide I′ band of deuterated films of WLIP samples
deposited from a buffer solution (buffer, thick dotted line) or after binding to the
lipid membrane (POPC, solid line). The original spectrum (POPC) was
deconvoluted and curve fitted to resolve the component frequencies. The
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Studies of dynamic light scattering (DLS) showed that the
treatment of PC LUVs (80 μM) with LDPs at a toxin to lipid
molar ratio (T/L) lower than 0.3, caused only a slight increase
of vesicle average size (Fig. 3) which was less than 20% for
both WLIP and tolaasin I.
At these toxin concentrations the release of calcein was
lower than 70%. Therefore, at such doses both toxins are
able to form pore-like lesions which allow calcein efflux
without causing any destruction of the vesicles. A further
increase of WLIP concentration (higher than 27 μM) induced
a decrease of vesicles average size with a concomitant
marked decrease of the scattered light intensity (Fig. 3 and
Inset), typical of a detergent-like activity through vesicles
micellization. This effect was not observed in the case of
tolaasin I, at least at concentrations up to ≈28 μM, which
induced only a slight decrease in the intensity of the
scattered light (less than 35%).
3.3. Fourier-transform infrared spectroscopy experiments
FTIR spectroscopy was used to determine the LDPs
conformation and to follow its changes when molecules
passed from a hydrophilic to a membrane mimetic environ-
ment. For this reason, FTIR spectra were collected either in
buffer solution, in an organic solvent (TFE, HFIP), in SDS
solution or in the presence of lipid vesicles. For our analysisFig. 4. Differential spectra after H/D exchange of the WLIP amide protons:
Analysis of differences in the amide I band of films of WLIP samples deposited
from a buffer solution (B, dashed line), TFE (T, dotted line), HFIP (H, solid
line), SDS (S, thick dashed line) and after binding to the lipid membrane (L,
thick dotted-dashed line). Differential spectra were obtained by subtracting the
hydrogenated spectra of WLIP in the different environments from the
corresponding deuterated spectra. Inset: Area of negative peaks between 1710
and 1660 cm−1. All the differences are between normalized spectra, i.e., with the
amide I′ peak area set at 1.
corresponding Gaussian bands are reported as dotted lines, and their sum as a
thick dashed line superimposed to the original spectrum. (B) Differential spectra
were obtained by subtracting the deuterated spectrum of the soluble form in
buffer from that in TFE (1), in HFIP (3), in SDS (2) or in presence of the lipid
phase (4).we considered the absorption of the amide I region after a
complete deuteration, i.e. after exchange of amide protons
with deuterium atoms (amide I′). Firstly, the exchange rate is
dependent on both the extent of hydrogen bonds (since these
bonds must be broken for the exchange to occur), and on the
accessibility of a given proton. As a consequence, hydrogen/
deuterium (H/D) exchange provides information about the
local structure of the molecule. Moreover, helical and
unordered structure contribute to the amide I vibration at
almost identical wavenumbers making therefore difficult the
precise determination of helix and random coil structures
from the IR spectra. However, after H/D exchange it is
possible to discriminate between these structures because of
changes in the random coil absorption, which shifts to a
higher extent than the helical component absorption.
In the case of WLIP, differential spectra obtained after the
H/D exchange in different environments (Fig. 4) showed a
decrease of absorption at 1670 cm−1 and a corresponding
increment at lower frequency (1634 cm−1). As appears from a
comparison of areas from the negative peaks centred at
1670 cm−1 (inset of Fig. 4), this effect decreased passing
from the buffer solution to a more hydrophobic environment
(either the solvent or the lipid membrane).
Fig. 6. Analysis of FTIR-ATR spectra of tolaasin I in POPC layers with
polarizer: (A) Spectra were taken with either parallel (0°) or perpendicular (90°)
polarization. The amide I′ region of tolaasin I bound to vesicles was reported
after subtraction of the lipid contribution. The best fit curve with Gaussian
components (dotted lines) was superimposed as a thick dashed line to the 90°
polarized trace (solid line). The absorption bands in the parallel and
perpendicular configuration were used to calculate the orientation of the
corresponding structural element as reported in Table 3. Bands are: h (helix), β
(β-structure), r (random). (B) Dichroic spectrum obtained by subtracting the 90°
polarized spectrum (after multiplication by Riso i.e. 1.54) from that at 0°.
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spectra, obtained by subtracting the deuterated spectrum of the
soluble form in buffer from those collected in all other
environments, are plotted. An excess of absorbance at about
1670 cm−1 was observed, with the concomitant decrease of
absorption at 1634 cm−1. The effect was maximum upon
interaction with the lipid membrane.
By applying the curve fitting procedure to the amide I′ peak
of WLIP in lipid (Fig. 5A), we calculated changes of absorption
in comparison with the soluble form in buffer. The results show
an increment from 11 to 26% and a decrease from 44 to 26% in
the regions centred at 1672 cm− 1 and at 1634 cm− 1,
respectively.
Furthermore, polarization experiments indicated that
WLIP had some disordering effect on the lipid membrane:
the average orientation of lipid chains with respect to the
normal to the plane changed from 34° to 41° upon
interaction (Table 3), a typical change induced by proteins
inserted into the membrane [29,32].
In the case of tolaasin I, frequency component analysis of the
amide I′ band (Table 2) indicated very small changes, if any,
passing from the buffer solution to less polar solvents. The
structure was composed predominantly of helical component
(comprising 46% of the structure), random coil (28%) and
β-structure (27%).
Interestingly, upon interaction with the lipid membrane we
observed a significant increase of the helical structure (from 46
to 63%) at expenses of other components, i.e. random coil
(which decreased from 28 to 15%) and β-structure (from 27 to
21%).
Finally, the orientation of the amide I′ band for tolaasin I
co-sedimented with LUVs was qualitatively analysed by
subtracting the 90° polarized spectrum (normalized by Riso)
from that at 0° (Fig. 6B): a clear positive deviation was
found at 1658 cm−1, typical of the helical component, which
suggested an orientation of this element, that became close to
parallel to the membrane normal [30]. From a quantitative
analysis of the polarized spectra of the inserted peptide (Fig.
6A), it was possible to calculate its dichroic ratio and
orientation around the perpendicular to the plane of the
membrane (Table 3) [32]. We obtained an average tilt angle
(γ⊥) of 47°. When we considered changes in the lipid chains
of LUVs upon interaction with tolaasin I, we noticed anTable 2
FTIR spectroscopy determination of the secondary structure of tolaasin I in
aqueous buffer, with and without lipids, and in different solvents
System % Secondary structure a
β h r
buffer 29 44 27
TFE 24 45 30
HFIP 24 48 28
SDS 27 47 26
POPC 21 63 15
a β: total β-structure (i.e. β-sheet, β-turn); h: helix; r: random. Errors of FTIR
determinations are ±5%.evident increment of the tilt angle of the lipid chains from
34° to 45°, meaning that the binding of the peptide caused
an increment of the lipid disorder. This value was used to
recalculate the relative orientation of the structure with
respect to the lipid chains [32], providing an angle (γL)
around 20°±2°. It suggested that tolaasin I was not only
bound to the membrane but also inserted in it and fully
immersed into the lipid core.
4. Discussion
In this paper the permeabilising activity of WLIP and
tolaasin I has been compared. Both LDPs are able to damage
biological and artificial membranes through the formation of
transmembrane pores. This was assessed also recently by Cho
et al. [19] who convincingly reported the ion channel forming
ability of tolaasin I, and by Lo Cantore et al. [3], who showed
evidences for pore formation of either WLIP or tolaasin I on
erythrocytes, using osmotic protectants. Consequently, we
investigated the activity of both LDPs on artificial membranes
formed by different combination of phospholipids, sphingo-
myelin and sterols, which are the main components of plasma
cell membranes.
Tolaasin I was more active on SM-containing membranes
than on LUVs of phospholipids alone and less active when
sterols were present. This feature was also observed for other
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for sterols [25,31] and apparently correlated to their cell
specificity, being more phytotoxic and less antifungal than the
nonapeptides syringomycines, pseudomycines and cormycin,
which showed a clear preference for sterols [20,25,31,33–36].
In the case of tolaasin I, the slight preference for ergosterol (a
fungal sterol) among sterols is consistent with its antifungal
activity.
Contrarily to our expectations, also WLIP, which is a
nonapeptide, was more active on SM-containing LUVs. It could
be explained by observing its structure which is more similar to
the peptine-like LDPs with only a portion of the peptide moiety
involved in the formation of the lactone ring. In comparison to
tolaasin I, the inhibitory effect of sterols was less effective on
the WLIP activity.
Nevertheless the two toxins showed similar responses to
changes of the lipid membrane composition, some interesting
differences appeared after analysis of data, all suggesting a
different mode of action.
Firstly, the parameter M (i.e., the molecularity of the
permeabilising unit) estimated from the Parente–Rapaport
model and reported in Table 1, was larger with WLIP and in
the same range of detergents [25]. In the case of tolaasin I, Cho
et al. [19] described the existence of subconductance states,
which could be related to the presence of pores with slightly
different molecularities. This instability of the pore structure
well correlates with the variability of the parameter M found by
our analysis.
For both LDPs the activity seemed mainly due to the ability
of monomers to bind to the liposome membrane (K1) rather than
to the two-dimensional aggregation rate (K2) of the bound
peptide.
A second difference comes from the light scattering signal.
From our results it was evident that WLIP at concentration
higher than 27 μM showed again a detergent-like activity; in
fact, the intensity of the scattered light felt down probably in
consequence of vesicles micellization. On the contrary, both
toxins at low concentration (at a toxin to lipid molar ratio up to
0.3) caused an increase of the liposome dimensions and a
decrease of the intensity of the diffused light. These effects well
correlated with vesicles aggregation, that increased the
measured diameters, and with precipitation of vesicle macro-
aggregates, which caused a decrease of signal intensity through
a decrease of the concentration of scattering centres.
Interestingly, the concentrations of WLIP and tolaasin I used
in our assays were of the same order of magnitude required to
cause mushroom tissue alteration in vivo [3,16,18]. Also the
different activity between the two LDPs was observed, being
WLIP about ten times less active than tolaasin I.
Our results, together with those reported in Lo Cantore et
al. [3], supported the idea of the cell membrane as the main
target for both WLIP and tolaasin I. Therefore it seemed
interesting to investigate the conformational changes occur-
ring when these molecules interacted with the lipid environ-
ment. The secondary structure of both of them was already
reported but only in the soluble form [10,21,37]. In particular
the conformation of tolaasin I was studied in SDS [21,37]:in this membrane-like environment it was showed the
presence of a left-handed α-helix, suggesting a refolding of
the structure from the aqueous buffer where the conformation
of the whole peptide was largely extended [37]. Considering
these results, the structure of peptides was analysed in the
lipid-mimetic conditions provided by TFE, HFIP and SDS, as
well as in the model lipid membrane of POPC liposome. We
expected changes in the secondary structure of peptides
passing from the buffer solution to the more hydrophobic
environment, with a maximum effect in the presence of the
lipid membrane.
In the case of WLIP, the rigidity of the molecule, a
nonapeptide cyclized via lactone formation between the third
and the C-terminal residues [10], could explain the slight
variation observed in the amide I′ spectrum even after the
interaction with the membrane. Moreover, the presence in the
same molecule of unusual residues made the assignment of a
secondary structure to the curve fitting components more
difficult. Therefore we focused on differential spectra obtained
after H/D exchange or after the buffer substitution with a
membrane-like environment.
In fact, variations of spectra after H/D exchange provided
information about the local structure of the molecule. The
decrease of absorption at 1670 cm−1 (and the corresponding
increment at 1634 cm−1), for example, indicated the presence
of free protons (i.e. not involved in hydrogen bonds) which
were able to exchange with deuterium, probably because of
their good accessibility allowed by the local structure of the
molecule. It could be attributed to a turn configuration with
fast exchanging protons. Interestingly, this behaviour was
depended on the solvent used and decreased in a lipid-mimetic
environment (effect measured by the small negative and
positive peaks at 1670 cm−1 and 1634 cm−1, respectively),
suggesting a decrease of the proton accessibility and,
consequently, a change in the local structure of the molecule.
We deduce that the lipid-mimetic conditions enhanced the
formation of hydrogen bonds inside the structure which
changed, becoming less susceptible to deuteration. Similar
changes were confirmed in differential spectra obtained by
subtracting the deuterated spectrum of the soluble form in
buffer, from those collected in all the other solvents. Variations
in the absorption were at the same wavenumbers described
above, showing an increment at 1670 cm−1 and a correspond-
ing decrease at 1634 cm−1 with the maximum in the lipid
membrane. These changes were in favour of a more stable
local structure which was enhanced from the lipid-mimetic
environments and that could be able to interact with the
membrane and its hydrophobic moiety. In addition, the
disordering effect on the vesicles membrane induced by the
binding of WLIP supports the hypothesis of an insertion of the
molecule into the membrane lipid core.
According to what we expected, we noticed an increment
of the helical content in the structure of tolaasin I when it
passed from the buffer solution to the membrane-like
environment. This could be consistent with results obtained
by CD and NMR spectroscopy in aqueous solution and in
SDS, respectively [21,37], although some observations need
Table 3
Assignment and dichroic ratio of some IR bands observed in lipid vesicles with
and without toxin
Wavenumber
(cm−1)
Vibration a Direction
(θ) b
Dichroic
ratio
Angle
(γ⊥)
c
Lipid alone
2920 as CH2 stretching 90° 1.32±0.01 33°±1°
2850 s CH2 stretching 90° 1.34±0.01 34°±1°
LUVs+WLIP
2920 as CH2 stretching 90° 1.48±0.01 41°±1°
2850 s CH2 stretching 90° 1.52±0.01 42°±1°
LUVs+tolaasin I
2920 as CH2 stretching 90° 1.61±0.01 45°±1°
2850 s CH2 stretching 90° 1.63±0.01 45°±1°
1660 Amide I′ helix 30° 2.51±0.10 47°±2°
a as: asymmetric, s: symmetric.
b Direction of the variation of the dipole moment associated to the vibration
with respect to the direction of the mainmolecular axis (aliphatic chain orα-helix
axis).
c Average angle between the direction of the molecular axis and the
perpendicular to the crystal plane (i.e. membrane plane).
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moiety of tolaasin I (18 aminoacids) includes unusual
residues and with D-chirality, so the standard assignment
of secondary structures to the curve fit components could be
not always applied. Interesting studies were recently reported
on α-helical membrane lytic peptides in which a few L-
amino acids were replaced with their D-enantiomers:
incremented amide I′ frequencies (1656–1670 cm−1) com-
pared with pure α-helical structures (1645–1654 cm−1) were
observed and assigned to 310-helix or dynamic/distorted α-
helix [38]. Previous studies had correlated this region with
310-helix [39], β-turn [40] and interestingly to a left-handed
α-helix, as well [41,42].
In our analysis we found indeed two components around
the typical region of helix absorption, centred at 1654 cm−1
and 1664 cm−1, respectively (data not shown).
We noticed that after deuteration the position of both peaks
did not change, suggesting a stable structure maintained by
hydrogen bonds, like a helix. Moreover, the sum of percentage
absorption of these two components kept at a constant value,
independently of the environment (i.e. buffer, solvents and
membranes), on the contrary the single absorptions changed:
the peak at 1654 cm−1 increased passing from buffer to
solvents at expenses of peaks at 1664 cm−1. After interaction
with the membrane, the contribution of the former was
maximum but analysis of the dichroic spectrum showed only
one peak at higher wavenumber (1659 cm−1). For all these
reasons, we joined the two contributions in an unique peak and
we assigned to it an helix structure which finally resulted the
conformation adopted from tolaasin I to bind the membrane
and to insert in it. The significant decrease in the orientation
order parameter of the aliphatic chain region (Table 3) and the
orientation of tolaasin I in the lipid bilayer prompt us to
interpret our results in favour of a barrel-stave mechanism ofaction versus a carpet like hypothesis [43]. This is indeed in
agreement with Jourdan et al. [37] who described for tolaasin I
the formation of a stable amphipathic helical structure and
suggested its insertion into the lipid matrix for the formation of
an ionic channel.
On the contrary, a carpet-like mechanism was previously
proposed for magainin derived lipopeptides which localized
on the membrane surface and did not significantly destabilise
the acyl-chain order. In fact, Avrahami et al. [44] observed
negative order parameters for both natural magainin and lipo-
magainin (magainin analogues conjugated with lipophilic
acids), typical of helices oriented nearly parallel to the
membrane surface. In addition, after incorporation of the
peptides into the lipid membrane, the lipid order was only
poorly disturbed and to the same extent, suggesting that both
peptides did not insert deeply into the lipid core.
A different mechanism of action could be proposed for
WLIP, in agreement with the evidences here reported for
membrane disruption in a detergent-like manner. In fact, it
does not have a sufficient length to transverse the entire
membrane, similarly to syringomicin for which Malev et al.
[45] hypothesized a toroidal pore.
In summary, the results described in this paper shed light
on the permeabilising effects induced by WLIP and tolaasin
I on liposome, and on the secondary structure occurring in
these molecules during their interaction with the lipid
membrane, which is their biological target.Acknowledgements
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